ARCHIVES

OMB Reprogramming Ban Criticized

This article is from The Cancer Letter archive.

Vol. 11 No. 36 | September 20, 1985

Download PDF Visit The Full Archive

Related Articles

Gleevec First Pediatric Cancer Approval By FDA In 13 Years

May 30, 2003

Eight Scientists Receive $800,000 From Milken

January 12, 1990

Frozen Serum Panels Available For Assays

June 8, 1984

Obituary: Piotr Kulesza, 46, Pathologist At Northwestern, ECOG-ACRIN, Dies in Fall After Group Meeting

November 22, 2013

Interview: Von Eschenbach Says His Goal Is to Speed Development of Interventions

March 29, 2002

Also in This 8-page Issue: NCI Seeks $6.17 Billion in “Bypass” Budget Request, But Faces Shortfall In Its Actual Budget.

January 14, 2005